Advanced glycation end products contribute to the immunogenicity of IFN-β pharmaceuticals

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of allergy and clinical immunology 2012-03, Vol.129 (3), p.855-858.e6
Hauptverfasser:	Bozhinov, Angelina, PhD, Handzhiyski, Yordan, PhD, Genov, Krasimir, MD, PhD, Daskalovska, Vera, MD, DSc, Niwa, Toshimitsu, MD, PhD, Ivanov, Ivan, DSc, Mironova, Roumyana, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Allergy and Immunology Animals Antibodies, Neutralizing - biosynthesis Biological and medical sciences CHO Cells Cricetinae Enzyme-Linked Immunosorbent Assay Escherichia coli Female Fundamental and applied biological sciences. Psychology Fundamental immunology Glycation End Products, Advanced - immunology Glycation End Products, Advanced - metabolism Glycosylation Haptens - immunology Haptens - metabolism Humans Imidazoles - metabolism Immunopathology Immunotherapy Interferon-beta - administration & dosage Interferon-beta - immunology Interferon-beta - metabolism Lysine - analogs & derivatives Lysine - metabolism Male Medical sciences Multiple Sclerosis, Relapsing-Remitting - drug therapy Multiple Sclerosis, Relapsing-Remitting - immunology Protein Processing, Post-Translational Recombinant Proteins - administration & dosage Recombinant Proteins - immunology Recombinant Proteins - metabolism Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!